Contract 36E79725A0009
Merz Pharmaceuticals, Llc · Department Of Veterans Affairs · March 12, 2025
Merz Pharmaceuticals, Llc was awarded a federal contract by Department Of Veterans Affairs on March 12, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79719D0246. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 29, 2026. If all options are exercised, the contract could reach $12.06 million.
Contract details
- PIID
- 36E79725A0009
- Parent IDIQ
- 36F79719D0246
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 12, 2025
- Latest action
- January 29, 2026
Description
EXERCISE OPTION YEAR 1 - BPA 36E79725A0009
Modification timeline
-
January 29, 2026Mod P00002$0
-
December 10, 2025Mod P000012026 PUBLIC LAW PRICING UPDATES.$0
-
March 12, 2025Base awardBPA FOR AMPYRA AND INBRIJIA$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79725A0009?
Contract 36E79725A0009 is a federal contract awarded to Merz Pharmaceuticals, Llc by Department Of Veterans Affairs on March 12, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36E79725A0009?
Merz Pharmaceuticals, Llc won contract 36E79725A0009 from Department Of Veterans Affairs.
How much is contract 36E79725A0009 worth?
Contract 36E79725A0009 has obligated $0 to date but carries a potential ceiling of $12.06 million if fully funded and all options are exercised.